Orange Book product · Generic (ANDA)
CLOXACILLIN SODIUM
CLOXACILLIN SODIUM
At a glance
Apr 06, 1989
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 06, 1989
37 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
CLOXACILLIN SODIUM
Strength
EQ 125MG BASE/5ML
Dosage form
FOR SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 062978
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLOXACILLIN SODIUM
- —TEGOPENBrand (NDA)
NDA 050192 · APOTHECON
- —CLOXACILLIN SODIUMGeneric (ANDA)
ANDA 061452 · APOTHECON
- —CLOXACILLIN SODIUMGeneric (ANDA)
ANDA 062240 · TEVA
- —CLOXAPENGeneric (ANDA)
ANDA 061806 · GLAXOSMITHKLINE
- —CLOXAPENGeneric (ANDA)
ANDA 062233 · GLAXOSMITHKLINE
- —CLOXACILLIN SODIUMGeneric (ANDA)
ANDA 062268 · TEVA
- —TEGOPENGeneric (ANDA)
ANDA 061453 · APOTHECON
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
